Table 2.
Patient characteristics (T1-3N0M0)
| Characteristic | White (N = 1779) | Nonwhite (N = 246) | p value |
|---|---|---|---|
| Age | |||
| 66–69 | 320 (18.0%) | 40 (16.3%) | 0.25 |
| 70–74 | 407 (22.9%) | 67 (27.2%) | |
| 75–79 | 414 (23.3%) | 63 (25.6%) | |
| 80–84 | 348 (19.6%) | 47 (19.1%) | |
| 85+ | 290 (16.3%) | 29 (11.8%) | |
| Age (Mean, SD) | 76.9 (7.1) | 75.1 (6.5) | |
| Sex | |||
| Male | 1266 (72.2%) | 160 (65.0%) | 0.049 |
| Female | 513 (28.8%) | 86 (35.0%) | |
| Marital status | |||
| Unmarried | 648 (36.4%) | 133 (54.1%) | < 0.0001 |
| Married | 1038 (58.4%) | * | |
| Unknown | 93 (5.2%) | * | |
| Year of diagnosis | |||
| 2003–2005 | 611 (34.5%) | 103 (41.9%) | 0.03 |
| 2006–2008 | 608 (34.2%) | 83 (33.7%) | |
| 2009–2011 | 560 (31.5%) | 60 (24.4%) | |
| SEER region | |||
| Northeast | 406 (22.8%) | 32 (13.0%) | 0.0001 |
| South | 427 (24.0%) | 80 (32.5%) | |
| Midwest | 243 (13.7%) | 23 (9.4%) | |
| West/Hawaii | 703 (39.5%) | 111 (45.1%) | |
| SES** | |||
| 0 (lowest) | 240 (13.5%) | 104 (42.3%) | < 0.0001 |
| 1 | 337 (18.9%) | 48 (19.5%) | |
| 2 | 361 (20.3%) | 38 (15.5%) | |
| 3 | 415 (23.3%) | 34 (13.8%) | |
| 4 (highest) | 426 (24.0%) | 22 (8.9%) | |
| Histology | |||
| Adenocarcinoma | 1220 (68.6%) | 54 (22.0%) | < 0.0001 |
| Squamous cell carcinoma | 559 (31.4%) | 192 (78.15%) | |
| Stage | |||
| I | 1098 (61.7%) | 154 (62.6%) | 0.79 |
| II | 681 (38.3%) | 92 (37.4%) | |
| T stage | |||
| T1a | 369 (20.7%) | 29 (11.8%) | < 0.0001 |
| T1b | 166 (9.3%) | 14 (6.7%) | |
| T1NOS | 563 (31.7%) | 111 (45.1%) | |
| T2 | 286 (16.1%) | 41 (16.7%) | |
| T3 | 395 (22.2%) | 51 (20.7%) | |
| Charlson score | |||
| 0 | 745 (41.9%) | 105 (42.7%) | 0.83 |
| 1 | 502 (28.2%) | 65 (26.4%) | |
| 2+ | 532 (29.9%) | 76 (26.4%) | |
| Esophagus location | |||
| Lower | 1092 (61.4%) | 83 (33.7%) | <0.0001 |
| Middle | 375 (21.1%) | 107 (43.5%) | |
| Upper | 123 (6.9%) | 23 (9.4%) | |
| Unknown | 189 (10.6%) | 33 (13.4%) | |
| Surgery | |||
| No | 953 (53.6%) | 176 (71.5%) | < 0.0001 |
| Yes | 826 (46.4%) | 70 (28.4%) | |
| Radiation | |||
| No | 724 (40.7%) | 79 (32.1%) | 0.01 |
| Yes | 1055 (59.3%) | 167 (67.9%) | |
| Chemotherapy | |||
| No | 938 (52.7%) | 146 (59.4%) | 0.051 |
| Yes | 841 (47.3%) | 100 (40.7%) |
*
Values suppressed in accordance with SEER-Medicare guidelines to mask cell sizes that may be < 11 and ensure patient confidentiality. Percentages may not add to 100 due to rounding
**
SES: quintiles based on median income by census tract ZIP code